Potency of Anidulafungin Compared to Nine Other Antifungal Agents Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Results from the Global SENTRY Antimicrobial Surveillance Program (2008)
- 1 August 2010
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (8), 2984-2987
- https://doi.org/10.1128/jcm.00328-10
Abstract
The SENTRY Antimicrobial Surveillance Program regularly monitors global susceptibility rates for a spectrum of both novel and established antifungal agents. Anidulafungin and the other echinocandins displayed sustained, excellent activity against Candida spp. and Aspergillus fumigatus , with ≥98% of MIC results at ≤2 μg/ml. Six yeast isolates (all Candida glabrata ) showing caspofungin MIC values of ≥0.5 μg/ml were further analyzed for potential fks hot spot (HS) mutations; three isolates had confirmed mutations in the fks1 HS1 region (S645P), and three exhibited mutations in the fks2 HS1 region (S645F and S645P).Keywords
This publication has 14 references indexed in Scilit:
- Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)Journal of Clinical Microbiology, 2009
- Mutations in the fks1 Gene in Candida albicans , C. tropicalis , and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility TestingAntimicrobial Agents and Chemotherapy, 2008
- Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC BreakpointsJournal of Clinical Microbiology, 2008
- Quality Control and Reference Guidelines for CLSI Broth Microdilution Method (M38-A Document) for Susceptibility Testing of Anidulafungin against MoldsJournal of Clinical Microbiology, 2007
- Acquired resistance to echinocandins in Candida albicans: case report and reviewJournal of Antimicrobial Chemotherapy, 2007
- Reviews Of Anti‐infective Agents: New Agents for the Treatment of Fungal Infections: Clinical Efficacy and Gaps in CoverageClinical Infectious Diseases, 2006
- Initial results from a longitudinal international surveillance programme for anidulafungin (2003)Journal of Antimicrobial Chemotherapy, 2004
- In Vitro Activity of Anidulafungin against Selected Clinically Important Mold IsolatesAntimicrobial Agents and Chemotherapy, 2004
- The Epidemiology of Hematogenous Candidiasis Caused by Different Candida SpeciesClinical Infectious Diseases, 1997
- Emergence of Cryptococcal Disease: Epidemiologic Perspectives 100 Years after Its DiscoveryEpidemiologic Reviews, 1995